|
Real-time
Euronext Paris
08:40:29 31/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 14.08 EUR | -2.09% |
|
+1.29% | +167.43% |
| 03/07 | Genfit soars on news of U.S. reimbursement for a product |  |
| 03/07 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 72Cr 83Cr 67Cr 62Cr 115.99Cr 7.98TCr 116.35Cr 800.19Cr 312.21Cr 4.03TCr 313.43Cr 306.61Cr 13TCr | P/E 2026 * |
37.1x | P/E 2027 * | 95.5x |
|---|---|---|---|---|---|
| Enterprise Value | 67Cr 78Cr 63Cr 57Cr 107.74Cr 7.41TCr 108.09Cr 743.33Cr 290.02Cr 3.74TCr 291.15Cr 284.82Cr 12TCr | EV / Sales 2026 * |
6.67x | EV / Sales 2027 * | 5.27x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.39% | ||
| 1 week | +2.01% | ||
| Current month | -3.27% | ||
| 1 month | -3.27% | ||
| 3 months | +65.46% | ||
| 6 months | +67.32% | ||
| Current year | +169.33% |
| 1 week | 13.92 |  | 14.98 |
| 1 month | 12.74 | | 15.2 |
| Current year | 5.05 | | 15.48 |
| 1 year | 3.05 | | 15.48 |
| 3 years | 2.62 | | 15.48 |
| 5 years | 2.62 | | 15.48 |
| 10 years | 2.62 | | 35.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 16/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 22/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 27/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 16/06/2017 | |
| Director/Board Member | 54 | 15/09/1999 | |
| Director/Board Member | 58 | 16/06/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 05/03/26 | Exercice | Chief Operating Officer | 11,250 | 0.0225% | ||
| 05/03/26 | Exercice | Chief Operating Officer | 7,083 | 0.0142% | ||
| 05/03/26 | Sell | Chief Operating Officer | 7,083 | 0.0142% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.39% | +2.01% | +310.30% | +328.40% | 83Cr | |
| -0.72% | -1.57% | +1.33% | +18.35% | 5.05TCr | |
| -6.00% | -0.75% | +447.48% | +524.26% | 4.46TCr | |
| -0.24% | +0.74% | +37.18% | +16.57% | 4.31TCr | |
| -1.55% | -2.07% | +19.83% | +73.63% | 4.17TCr | |
| -0.31% | -0.83% | +19.47% | +48.24% | 3.32TCr | |
| -1.79% | -3.24% | +26.32% | +121.63% | 1.68TCr | |
| -0.58% | -2.12% | - | - | 1.63TCr | |
| +0.03% | -1.17% | +11.42% | +27.38% | 1.46TCr | |
| -1.66% | -1.25% | +78.49% | +39.02% | 1.39TCr | |
| Average | -1.30% | -1.28% | +105.76% | +133.05% | 2.75TCr | |
| Weighted average by Cap. | -1.65% | -1.21% | +96.64% | +127.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10Cr 12Cr 9.39Cr 8.58Cr 16Cr 1.11TCr 16Cr 111.46Cr 43Cr 560.98Cr 44Cr 43Cr 1.86TCr | 12Cr 14Cr 12Cr 11Cr 20Cr 1.38TCr 20Cr 137.99Cr 54Cr 694.52Cr 54Cr 53Cr 2.3TCr |
| Net income | 2.29Cr 2.65Cr 2.15Cr 1.96Cr 3.69Cr 253.75Cr 3.7Cr 25Cr 9.93Cr 128.09Cr 9.97Cr 9.75Cr 424.73Cr | 68L 78.91L 63.76L 58.2L 1.1Cr 75Cr 1.1Cr 7.56Cr 2.95Cr 38Cr 2.96Cr 2.9Cr 126.24Cr |
| Net Debt | -5.11Cr -5.93Cr -4.79Cr -4.38Cr -8.24Cr -566.96Cr -8.27Cr -57Cr -22Cr -286.2Cr -22Cr -22Cr -948.98Cr | -6.62Cr -7.68Cr -6.2Cr -5.66Cr -11Cr -733.95Cr -11Cr -74Cr -29Cr -370.49Cr -29Cr -28Cr -1.23TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | €14.08 | -2.09% | 2,28,947 |
| 28/26/28 | €14.38 | -0.96% | 2,94,675 |
| 27/26/27 | €14.52 | +2.11% | 1,71,883 |
| 26/26/26 | €14.22 | -0.56% | 2,46,222 |
| 25/26/25 | €14.30 | +2.88% | 1,90,089 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
Select your edition
All financial news and data tailored to specific country editions
